- Home
- APLT vs AMSC Comparison
APLT vs AMSC Comparison
Compare APLT & AMSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- AMSC
- Stock Information
- Founded
- APLT 2016
- AMSC 1987
- Country
- APLT United States
- AMSC United States
- Employees
- APLT N/A
- AMSC N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- AMSC Metal Fabrications
- Sector
- APLT Health Care
- AMSC Consumer Discretionary
- Exchange
- APLT Nasdaq
- AMSC Nasdaq
- Market Cap
- APLT 44.0M
- AMSC 1.1B
- IPO Year
- APLT 2019
- AMSC 1991
- Fundamental
- Price
- APLT $0.42
- AMSC $40.96
- Analyst Decision
- APLT Buy
- AMSC Strong Buy
- Analyst Count
- APLT 7
- AMSC 3
- Target Price
- APLT $6.10
- AMSC $33.67
- AVG Volume (30 Days)
- APLT 2.7M
- AMSC 1.1M
- Earning Date
- APLT 08-06-2025
- AMSC 08-05-2025
- Dividend Yield
- APLT N/A
- AMSC N/A
- EPS Growth
- APLT N/A
- AMSC N/A
- EPS
- APLT N/A
- AMSC 0.16
- Revenue
- APLT $265,000.00
- AMSC $222,818,000.00
- Revenue This Year
- APLT $1,768.13
- AMSC $20.26
- Revenue Next Year
- APLT $292.85
- AMSC $12.73
- P/E Ratio
- APLT N/A
- AMSC $255.31
- Revenue Growth
- APLT N/A
- AMSC 52.99
- 52 Week Low
- APLT $0.30
- AMSC $13.98
- 52 Week High
- APLT $10.62
- AMSC $41.40
- Technical
- Relative Strength Index (RSI)
- APLT 60.22
- AMSC 73.46
- Support Level
- APLT $0.32
- AMSC $38.45
- Resistance Level
- APLT $0.36
- AMSC $40.53
- Average True Range (ATR)
- APLT 0.04
- AMSC 2.04
- MACD
- APLT 0.01
- AMSC 0.07
- Stochastic Oscillator
- APLT 88.67
- AMSC 94.72
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.